Bio-Rad Laboratories (BIO) Common Equity (2009 - 2026)
Bio-Rad Laboratories' Common Equity came in at $7.6 billion for Q3 2026, up 12.9% from $6.74 billion a year earlier and up 6.0% from the prior quarter.
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Bio-Rad Laboratories' Common Equity was $7.45 billion, up 13.5% from FY2024.
- Common Equity carries a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
- Going back by year, Common Equity was $6.57 billion in FY2024 (-24.8%), $8.74 billion in FY2023 (-9.1%), $9.62 billion in FY2022 (-29.7%) and $13.69 billion in FY2021 (+38.4%).
- The Q3 2026 figure represents the highest quarterly Common Equity since Q1 2024.
- Year-over-year, Common Equity has increased for four consecutive quarters, with an average decline of 3.3% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2021 (growth of 38.4%), and the weakest in Q3 2022 (a decline of 44.7%).
- Business Quant data shows BIO's Common Equity at $7.17 billion (Q2 2026), $6.85 billion (Q1 2026) and $7.45 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 259.44 Bn | 236.08 Bn | 5.13 Bn | 54.77 Bn |
| 2 | Abbott Laboratories | 187.98 Bn | 162.45 Bn | 7.39 Bn | 51.62 Bn |
| 3 | Danaher | 163.91 Bn | 143.58 Bn | 3.84 Bn | 53.63 Bn |
| 4 | Intuitive Surgical | 153.75 Bn | 134.17 Bn | 2.08 Bn | 16.12 Bn |
| 5 | Medtronic | 131.67 Bn | 97.80 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 117.84 Bn | 104.03 Bn | 4.25 Bn | 23.46 Bn |
| 7 | Boston Scientific | 64.27 Bn | 59.95 Bn | 3.43 Bn | 25.87 Bn |
| 8 | Edwards Lifesciences | 61.69 Bn | 45.00 Bn | 1.35 Bn | 10.96 Bn |
| 9 | Medline | 51.94 Bn | 49.07 Bn | 1.93 Bn | 19.39 Bn |
| 10 | Bio-Rad Laboratories | 9.85 Bn | 3.46 Bn | 328.60 Mn | 7.60 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.60 Bn |
| Jun 30, 2026 | 7.17 Bn |
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.45 Bn |
| Sep 30, 2025 | 6.74 Bn |
| Jun 30, 2025 | 7.13 Bn |
| Mar 31, 2025 | 6.68 Bn |
| Dec 31, 2024 | 6.57 Bn |
| Sep 30, 2024 | 7.49 Bn |
| Jun 30, 2024 | 6.78 Bn |
| Mar 31, 2024 | 9.05 Bn |
| Dec 31, 2023 | 8.74 Bn |
| Sep 30, 2023 | 8.42 Bn |
| Jun 30, 2023 | 8.45 Bn |
| Mar 31, 2023 | 9.76 Bn |
| Dec 31, 2022 | 9.62 Bn |
| Sep 30, 2022 | 8.48 Bn |
| Jun 30, 2022 | 8.95 Bn |
| Mar 31, 2022 | 10.20 Bn |
| Dec 31, 2021 | 13.69 Bn |
API Access
Bio-Rad Laboratories Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();